RESUMO
BACKGROUND: Current non-invasive biomarkers for Crohn's disease are limited in their utility. Progress in identifying individual autoantigens and autoantibodies in Crohn's disease has been challenging due to limitations of available immunoassays. AIMS: Our aim was to identify autoantibodies associated with Crohn's disease that may be useful in diagnosis and management using an innovative protein array technology, namely nucleic acid programmable protein arrays [NAPPA]. METHODS: Serum samples of 96 patients with established Crohn's disease and 96 healthy controls were included and evenly split into discovery and validation sets randomly. Autoantibodies of both IgG and IgA classes were profiled against ~1900 human proteins in the discovery set on NAPPA. Autoantibodies discovered to be Crohn's disease-specific were further validated in the independent validation set by enzyme-linked immunosorbent assay. RESULTS: Overall, reactivity of IgG autoantibodies was stronger than that of IgA autoantibodies; however, IgA autoantibodies showed greater differential reactivity between cases and controls. Four IgA autoantibodies against SNRPB, PRPH, PTTG1 and SNAI1 were newly identified with sensitivities above 15% at 95% specificity, among which anti-SNRPB-IgA had the highest sensitivity of 24.0%. Autoantibodies associated with specific disease subtypes were also found. CONCLUSIONS: As one of the first studies to use immunoproteomics for the identification of autoantibodies in Crohn's disease, our results support the utility of NAPPA in implementing future expanded studies with better coverage of the human proteome and microbial proteomes relevant to Crohn's disease and identifying antibody markers that may have clinical impact in diagnosis and management.
Assuntos
Anticorpos/sangue , Doença de Crohn/imunologia , Imunoglobulina A/sangue , Imunoglobulina G/sangue , Proteínas Centrais de snRNP/imunologia , Adolescente , Adulto , Idoso , Biomarcadores/sangue , Estudos de Casos e Controles , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Periferinas/imunologia , Análise Serial de Proteínas/métodos , Proteômica/métodos , Distribuição Aleatória , Securina/imunologia , Sensibilidade e Especificidade , Fatores de Transcrição da Família Snail/imunologia , Adulto JovemRESUMO
We performed an unbiased proteome-scale profiling of humoral autoimmunity in recent-onset type 1 diabetes (T1D) patients and nondiabetic controls against â¼10â¯000 human proteins using a Nucleic Acid Programmable Protein Array (NAPPA) platform, complemented by a knowledge-based selection of proteins from genes enriched in human pancreas. Although the global response was similar between cases and controls, we identified and then validated six specific novel T1D-associated autoantibodies (AAbs) with sensitivities that ranged from 16 to 27% at 95% specificity. These included AAbs against PTPRN2, MLH1, MTIF3, PPIL2, NUP50 (from NAPPA screening), and QRFPR (by targeted ELISA). Immunohistochemistry demonstrated that NUP50 protein behaved differently in islet cells, where it stained both nucleus and cytoplasm, compared with only nuclear staining in exocrine pancreas. Conversely, PPIL2 staining was absent in islet cells, despite its presence in exocrine cells. The combination of anti-PTPRN2, -MLH1, -PPIL2, and -QRFPR had an AUC of 0.74 and 37.5% sensitivity at 95% specificity. These data indicate that these markers behave independently and support the use of unbiased screening to find biomarkers because the majority was not predicted based on predicted abundance. Our study enriches the knowledge of the "autoantibody-ome" in unprecedented breadth and width.
Assuntos
Autoanticorpos/genética , Ciclofilinas/imunologia , Diabetes Mellitus Tipo 1/imunologia , Proteína 1 Homóloga a MutL/imunologia , Proteínas Tirosina Fosfatases Classe 8 Semelhantes a Receptores/imunologia , Receptores Acoplados a Proteínas G/imunologia , Adolescente , Especificidade de Anticorpos , Autoanticorpos/biossíntese , Autoimunidade/genética , Biomarcadores/análise , Estudos de Casos e Controles , Criança , Ciclofilinas/genética , Diabetes Mellitus Tipo 1/diagnóstico , Diabetes Mellitus Tipo 1/genética , Diabetes Mellitus Tipo 1/patologia , Feminino , Humanos , Imunidade Humoral/genética , Masculino , Proteína 1 Homóloga a MutL/genética , Pâncreas/imunologia , Pâncreas/patologia , Análise Serial de Proteínas , Proteínas Tirosina Fosfatases Classe 8 Semelhantes a Receptores/genética , Receptores Acoplados a Proteínas G/genética , Sensibilidade e Especificidade , Adulto JovemRESUMO
The rapid rise in the incidence of type 1 diabetes (T1D) suggests the involvement of environmental factors including viral infections. We evaluated the association between viral infections and T1D by profiling antiviral antibodies using a high-throughput immunoproteomics approach in patients with new-onset T1D. We constructed a viral protein array comprising the complete proteomes of seven viruses associated with T1D and open reading frames from other common viruses. Antibody responses to 646 viral antigens were assessed in 42 patients with T1D and 42 age- and sex-matched healthy control subjects (mean age 12.7 years, 50% males). Prevalence of antiviral antibodies agreed with known infection rates for the corresponding virus based on epidemiological studies. Antibody responses to Epstein-Barr virus (EBV) were significantly higher in case than control subjects (odds ratio 6.6; 95% CI 2.0-25.7), whereas the other viruses showed no differences. The EBV and T1D association was significant in both sex and age subgroups (≤12 and >12 years), and there was a trend toward early EBV infections among the case subjects. These results suggest a potential role for EBV in T1D development. We believe our innovative immunoproteomics platform is useful for understanding the role of viral infections in T1D and other disorders where associations between viral infection and disease are unclear.
Assuntos
Anticorpos Antivirais/imunologia , Diabetes Mellitus Tipo 1/imunologia , Herpesvirus Humano 4/imunologia , Proteínas Virais/imunologia , Adolescente , Adulto , Autoanticorpos/imunologia , Estudos de Casos e Controles , Proteínas de Transporte de Cátions/imunologia , Criança , Pré-Escolar , Infecções por Coxsackievirus/imunologia , Citomegalovirus/imunologia , Infecções por Citomegalovirus/imunologia , Diabetes Mellitus Tipo 1/virologia , Retrovirus Endógenos/imunologia , Enterovirus Humano B/imunologia , Infecções por Vírus Epstein-Barr , Feminino , Glutamato Descarboxilase/imunologia , Ensaios de Triagem em Larga Escala , Humanos , Masculino , Caxumba/imunologia , Vírus da Caxumba/imunologia , Análise Serial de Proteínas , Proteômica , Rotavirus/imunologia , Infecções por Rotavirus/imunologia , Rubéola (Sarampo Alemão)/imunologia , Vírus da Rubéola/imunologia , Adulto Jovem , Transportador 8 de ZincoRESUMO
We report a device to fill an array of small chemical reaction chambers (microreactors) with reagent and then seal them using pressurized viscous liquid acting through a flexible membrane. The device enables multiple, independent chemical reactions involving free floating intermediate molecules without interference from neighboring reactions or external environments. The device is validated by protein expressed in situ directly from DNA in a microarray of ~10,000 spots with no diffusion during three hours incubation. Using the device to probe for an autoantibody cancer biomarker in blood serum sample gave five times higher signal to background ratio compared to standard protein microarray expressed on a flat microscope slide. Physical design principles to effectively fill the array of microreactors with reagent and experimental results of alternate methods for sealing the microreactors are presented.
Assuntos
DNA/genética , Perfilação da Expressão Gênica/instrumentação , Análise de Sequência com Séries de Oligonucleotídeos/instrumentação , Proteômica/instrumentação , Desenho de Equipamento , Humanos , Proteoma/genética , Proteoma/metabolismo , Reprodutibilidade dos TestesRESUMO
AMPylation (adenylylation) is a recently discovered mechanism employed by infectious bacteria to regulate host cell signaling. However, despite significant effort, only a few host targets have been identified, limiting our understanding of how these pathogens exploit this mechanism to control host cells. Accordingly, we developed a novel nonradioactive AMPylation screening platform using high-density cell-free protein microarrays displaying human proteins produced by human translational machinery. We screened 10,000 unique human proteins with Vibrio parahaemolyticus VopS and Histophilus somni IbpAFic2, and identified many new AMPylation substrates. Two of these, Rac2, and Rac3, were confirmed in vivo as bona fide substrates during infection with Vibrio parahaemolyticus. We also mapped the site of AMPylation of a non-GTPase substrate, LyGDI, to threonine 51, in a region regulated by Src kinase, and demonstrated that AMPylation prevented its phosphorylation by Src. Our results greatly expanded the repertoire of potential host substrates for bacterial AMPylators, determined their recognition motif, and revealed the first pathogen-host interaction AMPylation network. This approach can be extended to identify novel substrates of AMPylators with different domains or in different species and readily adapted for other post-translational modifications.
Assuntos
Monofosfato de Adenosina/química , Proteínas de Bactérias/metabolismo , Química Click/métodos , Reação de Cicloadição , Processamento de Proteína Pós-Traducional/fisiologia , Sequência de Bases , Cobre/química , Interações Hospedeiro-Patógeno , Humanos , Pasteurellaceae/metabolismo , Análise Serial de Proteínas , Estrutura Terciária de Proteína , Vibrioses/patologia , Vibrio parahaemolyticus/metabolismo , Proteínas rac de Ligação ao GTP/metabolismo , Inibidor beta de Dissociação do Nucleotídeo Guanina rho/metabolismo , Proteína RAC2 de Ligação ao GTPRESUMO
DNA viruses often target cellular proteins to modulate host cell cycles and facilitate viral genome replication. However, whether proliferation of white spot syndrome virus (WSSV) requires regulation of the host cell cycle remains unclear. In the present study, we show that two WSSV paralogs, IE1 and WSV056, can interact with Litopenaeus vannamei retinoblastoma (Rb)-like protein (lv-RBL) through the conserved LxCxE motif. Further investigation revealed that IE1 and WSV056 could also bind to Drosophila retinoblastoma family protein 1 (RBF1) in a manner similar to how they bind to lv-RBL. Using the Drosophila RBF-E2F pathway as a model system, we demonstrated that both IE1 and WSV056 could sequester RBF1 from Drosophila E2F transcription factor 1 (E2F1) and subsequently activate E2F1 to stimulate the G1/S transition. Our findings provide the first evidence that WSSV may regulate cell cycle progression by targeting the Rb-E2F pathway.
Assuntos
Ciclo Celular , Infecções por Vírus de DNA/veterinária , Proteínas Imediatamente Precoces/metabolismo , Penaeidae/metabolismo , Penaeidae/virologia , Proteína do Retinoblastoma/metabolismo , Vírus da Síndrome da Mancha Branca 1/metabolismo , Sequência de Aminoácidos , Animais , Infecções por Vírus de DNA/genética , Infecções por Vírus de DNA/metabolismo , Infecções por Vírus de DNA/virologia , Fase G1 , Interações Hospedeiro-Patógeno , Proteínas Imediatamente Precoces/química , Proteínas Imediatamente Precoces/genética , Dados de Sequência Molecular , Penaeidae/citologia , Penaeidae/genética , Ligação Proteica , Proteína do Retinoblastoma/genética , Fase S , Alinhamento de Sequência , Vírus da Síndrome da Mancha Branca 1/química , Vírus da Síndrome da Mancha Branca 1/classificação , Vírus da Síndrome da Mancha Branca 1/genéticaRESUMO
We present a microarray nonlinear calibration (MiNC) method for quantifying antibody binding to the surface of protein microarrays that significantly increases the linear dynamic range and reduces assay variation compared with traditional approaches. A serological analysis of guinea pig Mycobacterium tuberculosis models showed that a larger number of putative antigen targets were identified with MiNC, which is consistent with the improved assay performance of protein microarrays. MiNC has the potential to be employed in biomedical research using multiplex antibody assays that need quantitation, including the discovery of antibody biomarkers, clinical diagnostics with multi-antibody signatures, and construction of immune mathematical models.